MDPI and ACS Style
Alshabrawy, A.K.; Cui, Y.; Sylvester, C.; Yang, D.; Petito, E.S.; Barratt, K.R.; Sawyer, R.K.; Heatlie, J.K.; Polara, R.; Sykes, M.J.;
et al. Therapeutic Potential of a Novel Vitamin D3 Oxime Analogue, VD1-6, with CYP24A1 Enzyme Inhibitory Activity and Negligible Vitamin D Receptor Binding. Biomolecules 2022, 12, 960.
https://doi.org/10.3390/biom12070960
AMA Style
Alshabrawy AK, Cui Y, Sylvester C, Yang D, Petito ES, Barratt KR, Sawyer RK, Heatlie JK, Polara R, Sykes MJ,
et al. Therapeutic Potential of a Novel Vitamin D3 Oxime Analogue, VD1-6, with CYP24A1 Enzyme Inhibitory Activity and Negligible Vitamin D Receptor Binding. Biomolecules. 2022; 12(7):960.
https://doi.org/10.3390/biom12070960
Chicago/Turabian Style
Alshabrawy, Ali K., Yingjie Cui, Cyan Sylvester, Dongqing Yang, Emilio S. Petito, Kate R. Barratt, Rebecca K. Sawyer, Jessica K. Heatlie, Ruhi Polara, Matthew J. Sykes,
and et al. 2022. "Therapeutic Potential of a Novel Vitamin D3 Oxime Analogue, VD1-6, with CYP24A1 Enzyme Inhibitory Activity and Negligible Vitamin D Receptor Binding" Biomolecules 12, no. 7: 960.
https://doi.org/10.3390/biom12070960